STIVARGA for Rectal cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where STIVARGA was used for Rectal cancer.
Most Reported Side Effects for STIVARGA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Palmar-plantar erythrodysaesthesia syndrome | 33 | 13.2% | 9 | 14 |
| Fatigue | 27 | 10.8% | 5 | 12 |
| Pyrexia | 27 | 10.8% | 8 | 14 |
| Diarrhoea | 24 | 9.6% | 6 | 12 |
| Decreased appetite | 23 | 9.2% | 9 | 10 |
| Dysphonia | 23 | 9.2% | 6 | 12 |
| Hypertension | 18 | 7.2% | 5 | 8 |
| Vomiting | 18 | 7.2% | 8 | 9 |
| Colon cancer | 17 | 6.8% | 15 | 3 |
| Nausea | 16 | 6.4% | 7 | 10 |
| Hepatic function abnormal | 15 | 6.0% | 8 | 10 |
| Colorectal cancer | 14 | 5.6% | 10 | 2 |
| Rash | 14 | 5.6% | 5 | 9 |
| Death | 13 | 5.2% | 13 | 6 |
| Malaise | 13 | 5.2% | 6 | 9 |
Other Indications for STIVARGA
Colon cancer (68)
Colorectal cancer (58)
Colorectal cancer metastatic (25)
Gastrointestinal stromal tumour (17)
Colon cancer metastatic (9)
Metastases to liver (7)
Other Drugs Used for Rectal cancer
CAPECITABINE (2,976)
OXALIPLATIN (2,402)
FLUOROURACIL (1,610)
BEVACIZUMAB (1,546)
TIPIRACIL\TRIFLURIDINE (1,297)
IRINOTECAN (985)
LEUCOVORIN (660)
CETUXIMAB (542)
REGORAFENIB (505)
PANITUMUMAB (374)